Qube Research & Technologies (QRT)’s T2 Biosystems, Inc TTOO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	4853
2023 Q3	–	Hold	0	–	–	–	4387
2021 Q4	–	Sell	-6	Closed	-$26K	–	3076
2021 Q3	$26K	Buy	+6	New	+$30.2K	﹤0.01%	1946
2021 Q2	–	Sell	-11	Closed	-$86K	–	2915
2021 Q1	$86K	Sell	11 -57	-84%	-$604K	﹤0.01%	1752
2020 Q4	$423K	Sell	68 -13	-16%	-$79.6K	0.01%	1202
2020 Q3	$553K	Buy	81 +55	+212%	+$408K	0.01%	999
2020 Q2	$165K	Buy	+26	New	+$110K	﹤0.01%	1453

Other funds holding TTOO

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TTOO Position: Q4 2023 in Review

Qube Research & Technologies (QRT) held its T2 Biosystems, Inc (TTOO) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4853.

Qube Research & Technologies (QRT) first reported a position in TTOO in Q2 2020 and has held it in 5 quarters since. The position peaked at $553K in Q3 2020. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

Qube Research & Technologies (QRT) held 0 shares of T2 Biosystems, Inc worth $0 as of Q4 2023.
Qube Research & Technologies (QRT) left its T2 Biosystems, Inc share count unchanged in Q4 2023.
T2 Biosystems, Inc made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q4 2023, its #4853 holding.
Qube Research & Technologies (QRT) first reported a position in T2 Biosystems, Inc in Q2 2020 and has held it in 5 quarters since.
Qube Research & Technologies (QRT)'s T2 Biosystems, Inc position peaked at $553K in Q3 2020.
21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.